Who
Guy P. Nohra
Director
Company insider
Files Form 4 as: Director, TELA Bio; Director, Bioventus; 10% owner, Allakos; Director and 10% owner, ZS Pharma; Director, Carbylan Therapeutics; 10% owner, Evofem Biosciences; 10% owner, Esperion Therapeutics; 10% owner, Aerie Pharmaceuticals.
In numbers
- Trades disclosed
- 154
- Buys
- 8
- Sells
- 11
- Bought
- $30.4M
- Sold
- $13.4M
- Companies
- 12
- Companies where not an officer
- 12
- First trade
- 7 Nov 2006
- Last trade
- 9 Jun 2026
- Last filed
- 11 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,925 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,675 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,550 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,550 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,335 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA Biooption or derivative · Medical Devices | SEC FORM 4 Code A | —17,335 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,925 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | TELA TELA BioMedical Devices | SEC FORM 4 Code A | —11,675 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,146 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,146 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —32,282 at $0.00 | filing |
| 4 Dec 2025filed 8 Dec 2025 | BVS BioventusMedical Devices | SEC FORM 4 Sold | $76K10,000 at $7.57 | filing |
| 3 Jun 2025filed 4 Jun 2025 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —32,282 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —26,493 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | BVS BioventusMedical Devices | SEC FORM 4 Code M | —26,493 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code A | —26,493 at $0.00 | filing |
| 7 Jun 2024filed 11 Jun 2024 | BVS Bioventusoption or derivative · Medical Devices | SEC FORM 4 Code M | —30,400 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.